Gina Kolata
Posts
F.D.A. Approves Blood Test for Colon Cancer Detection
While not a perfect alternative to colonoscopies, experts hope the test could lead to more people getting screened for colorectal cancers.
FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.
Lead in Beethoven’s Hair Offers New Clues to Mystery of His Deafness
Using powerful technologies, scientists found staggering amounts of lead and other toxic substances in the composer’s hair that may have come from wine, or other...
Vertex Experimental Drug Cuts Off Pain at the Source, Company Says
Vertex Pharmaceuticals said its medicine could address moderate to severe acute pain, and might be able to avoid the risk of addiction.
Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients
The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing...
F.D.A. Experts Will Vote on a Cure for Sickle Cell Disease
The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR.
How Much Do Ozempic and Wegovy Cost? Not What You Think.
Drug companies are making billions from a new class of in-demand weight-loss treatments. But the prices are not what they seem.
3 Factors Keeping Americans From Wegovy and Other Weight-Loss Drugs
A survey showed that many Americans were interested in obesity treatments like Wegovy but lost interest when confronted with the price and other factors.
New Obesity Drugs Come With a Side Effect of Shaming
Wegovy and other drugs expose a social tension between a quest to medicate illness and a stigmatizing belief that obese people lack sufficient willpower to...
Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.